Investigational New Drug Services — Philadelphia, Pennsylvania

Investigational New Drug Services is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational New Drug Services has participated in 1 clinical trials.

Therapeutic areas: Alzheimer Disease.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational New Drug Services?

Investigational New Drug Services has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational New Drug Services conducted?

Investigational New Drug Services has 1 clinical trials on record. Their work covers Alzheimer Disease.

Is Investigational New Drug Services accredited by Crixeo Health?

Investigational New Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational New Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.